{
  "id": 26064,
  "title": "Alnylam's slump deepens; Q2 earnings roundup; and more",
  "url": "https://urgent.news/2026/08/01/alnylams-slump-deepens-q2-earnings-roundup-and-more",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-01T10:00:38.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/alnylams-slump-deepens-q2-earnings-roundup-and-more/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Welcome to another edition of Endpoints Weekly, and happy August! The summer is speeding right along, and we’ve got the latest from biopharma’s earnings-palooza this week. Let’s dive into the news. Alnylam’s struggles became the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}